- Home
- ECDA vs BLRX Comparison
ECDA vs BLRX Comparison
Compare ECDA & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECDA
- BLRX
- Stock Information
- Founded
- ECDA 2013
- BLRX 2003
- Country
- ECDA United States
- BLRX Israel
- Employees
- ECDA N/A
- BLRX N/A
- Industry
- ECDA Auto Manufacturing
- BLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ECDA Consumer Discretionary
- BLRX Health Care
- Exchange
- ECDA Nasdaq
- BLRX Nasdaq
- Market Cap
- ECDA 36.4M
- BLRX 36.0M
- IPO Year
- ECDA N/A
- BLRX 2011
- Fundamental
- Price
- ECDA $0.98
- BLRX $0.32
- Analyst Decision
- ECDA Strong Buy
- BLRX Strong Buy
- Analyst Count
- ECDA 1
- BLRX 2
- Target Price
- ECDA $9.00
- BLRX $11.50
- AVG Volume (30 Days)
- ECDA 45.5K
- BLRX 880.1K
- Earning Date
- ECDA 12-03-2024
- BLRX 11-25-2024
- Dividend Yield
- ECDA N/A
- BLRX N/A
- EPS Growth
- ECDA N/A
- BLRX N/A
- EPS
- ECDA N/A
- BLRX N/A
- Revenue
- ECDA $25,728,409.00
- BLRX $17,048,000.00
- Revenue This Year
- ECDA $125.56
- BLRX N/A
- Revenue Next Year
- ECDA $36.05
- BLRX N/A
- P/E Ratio
- ECDA N/A
- BLRX N/A
- Revenue Growth
- ECDA 123.27
- BLRX N/A
- 52 Week Low
- ECDA $0.75
- BLRX $0.32
- 52 Week High
- ECDA $17.00
- BLRX $1.89
- Technical
- Relative Strength Index (RSI)
- ECDA 46.52
- BLRX 34.04
- Support Level
- ECDA $0.82
- BLRX $0.44
- Resistance Level
- ECDA $1.03
- BLRX $0.56
- Average True Range (ATR)
- ECDA 0.10
- BLRX 0.04
- MACD
- ECDA -0.01
- BLRX 0.00
- Stochastic Oscillator
- ECDA 53.33
- BLRX 1.46
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the most customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.